Alternative activation of macrophages and induction of arginase are not components of pathogenesis mediated by Francisella species

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Griffin, Amanda J ^a   Crane, Deborah D ^a   Wehrly, Tara D ^a   Scott, Dana P ^b   Bosio, Catharine M ^a  

^a Rocky Mountain Veterinary Branch   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGINASE; ARGINASE 1; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CELL ACTIVATION; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVATION; EOSINOPHIL; FRANCISELLA TULARENSIS; GENETIC TRANSCRIPTION; IN VITRO STUDY; IN VIVO STUDY; LUNG LAVAGE; MACROPHAGE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; TULAREMIA;

ANIMALS; ARGINASE; CYTOKINES; ENZYME INDUCTION; FRANCISELLA TULARENSIS; LUNG; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; MICE, INBRED C57BL; TULAREMIA; VACCINES, ATTENUATED;

EID: 84891914349     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0082096     Document Type: Article

References (34)

1. Sjostedt A, editor (2005) Francisella. New York: Springer. 200-210 p.
2. Saslaw S, Eigelsbach HT, Prior JA, Wilson HE, Carhart S (1961) Tularemia vaccine study. II. Respiratory challenge. Arch Intern Med 107:702-714.
3. Dennis DT, Inglesby TV, Henderson DA, Bartlett JG, Ascher MS, et al. (2001) Tularemia as a biological weapon: medical and public health management. JAMA 285:2763-2773. (Pubitemid 32525374)
4. Risi GF, Pombo DJ (1995) Relapse of tularemia after aminoglycoside therapy: case report and discussion of therapeutic options. Clin Infect Dis 20:174-175.
5. Parker RR, Spencer RR (1926) Six Additional Cases of Laboratory Infection of Tularemia in Man. Public Health Reports 41:1341-1357.
6. Hall JD, Woolard MD, Gunn BM, Craven RR, Taft-Benz S, et al. (2008) Infected-host-cell repertoire and cellular response in the lung following inhalation of Francisella tularensis Schu S4, LVS, or U112. Infect Immun 76:5843-5852.
7. Bosio CM, Bielefeldt-Ohmann H, Belisle JT (2007) Active suppression of the pulmonary immune response by Francisella tularensis Schu4. J Immunol 178:4538-4547. (Pubitemid 46492406)
8. Chase JC, Bosio CM (2010) The presence of CD14 overcomes evasion of innate immune responses by virulent Francisella tularensis in human dendritic cells in vitro and pulmonary cells in vivo. Infect Immun 78:154-167.
9. Chase JC, Celli J, Bosio CM (2009) Direct and indirect impairment of human dendritic cell function by virulent Francisella tularensis Schu S4. Infect Immun 77:180-195.
10. Conlan JW, Zhao X, Harris G, Shen H, Bolanowski M, et al. (2008) Molecular immunology of experimental primary tularemia in mice infected by respiratory or intradermal routes with type A Francisella tularensis. Mol Immunol 45:2962-2969.
11. Shirey KA, Cole LE, Keegan AD, Vogel SN (2008) Francisella tularensis live vaccine strain induces macrophage alternative activation as a survival mechanism. J Immunol 181:4159-4167.
12. Gordon S (2003) Alternative activation of macrophages. Nat Rev Immunol 3:23-35. (Pubitemid 37328697)
13. Crane DD, Scott DP, Bosio CM (2012) Generation of a convalescent model of virulent Francisella tularensis infection for assessment of host requirements for survival of tularemia. PLoS One 7:e33349.
14. Elkins KL, Rhinehart-Jones TR, Culkin SJ, Yee D, Winegar RK (1996) Minimal requirements for murine resistance to infection with Francisella tularensis LVS. Infect Immun 64:3288-3293. (Pubitemid 26256178)
15. Jones JW, Kayagaki N, Broz P, Henry T, Newton K, et al. (2010) Absent in melanoma 2 is required for innate immune recognition of Francisella tularensis. Proc Natl Acad Sci U S A 107:9771-9776.
16. Crane DD, Ireland R, Alinger JB, Small P, Bosio CM (2013) Lipids derived from virulent Francisella tularensis broadly inhibit pulmonary inflammation via TLR2 and PPARalpha1. Clin Vaccine Immunol.
17. Bosio CM, Elkins KL (2001) Susceptibility to secondary Francisella tularensis live vaccine strain infection in B-cell-deficient mice is associated with neutrophilia but not with defects in specific T-cell-mediated immunity. Infect Immun 69:194-203. (Pubitemid 32040947)
18. Chase JC, Bosio CM (2009) Presence of CD14 overcomes evasion of innate immune responses by virulent Francisella tularensis in human dendritic cells in vitro and pulmonary cells in vivo. Infect Immun.
19. Checroun C, Wehrly TD, Fischer ER, Hayes SF, Celli J (2006) Autophagymediated reentry of Francisella tularensis into the endocytic compartment after cytoplasmic replication. Proc Natl Acad Sci U S A 103:14578-14583. (Pubitemid 44484792)
20. Crane DD, Warner SL, Bosio CM (2009) A novel role for plasmin-mediated degradation of opsonizing antibody in the evasion of host immunity by virulent, but not attenuated, Francisella tularensis. J Immunol 183:4593-4600.
21. Barron L, Wynn TA (2011) Macrophage activation governs schistosomiasisinduced inflammation and fibrosis. Eur J Immunol 41:2509-2514.
22. Takatsu K, Kouro T, Nagai Y (2009) Interleukin 5 in the link between the innate and acquired immune response. Adv Immunol 101:191-236.
23. Pearce EJ, La Flamme A, Sabin E, Brunet LR (1998) The initiation and function of Th2 responses during infection with Schistosoma mansoni. Adv Exp Med Biol 452:67-73. (Pubitemid 28478086)
24. Sabin EA, Kopf MA, Pearce EJ (1996) Schistosoma mansoni egg-induced early IL-4 production is dependent upon IL-5 and eosinophils. J Exp Med 184:1871-1878. (Pubitemid 26404477)
25. Sabin EA, Pearce EJ (1995) Early IL-4 production by non-CD4+ cells at the site of antigen deposition predicts the development of a T helper 2 cell response to Schistosoma mansoni eggs. J Immunol 155:4844-4853.
26. El Kasmi KC, Qualls JE, Pesce JT, Smith AM, Thompson RW, et al. (2008) Toll-like receptor-induced arginase 1 in macrophages thwarts effective immunity against intracellular pathogens. Nat Immunol 9:1399-1406.
27. Qualls JE, Subramanian C, Rafi W, Smith AM, Balouzian L, et al. (2012) Sustained generation of nitric oxide and control of mycobacterial infection requires argininosuccinate synthase 1. Cell Host Microbe 12:313-323.
28. Ketavarapu JM, Rodriguez AR, Yu JJ, Cong Y, Murthy AK, et al. (2008) Mast cells inhibit intramacrophage Francisella tularensis replication via contact and secreted products including IL-4. Proc Natl Acad Sci U S A 105:9313-9318.
29. Bosio CM (2011) The subversion of the immune system by francisella tularensis. Front Microbiol 2:9.
30. Jones CL, Napier BA, Sampson TR, Llewellyn AC, Schroeder MR, et al. (2012) Subversion of Host Recognition and Defense Systems by Francisella spp. Microbiol Mol Biol Rev 76:383-404.
31. Ireland R, Wang R, Alinger JB, Small P, Bosio CM (2013) Francisella tularensis SchuS4 and SchuS4 Lipids Inhibit IL-12p40 in Primary Human Dendritic Cells by Inhibition of IRF1 and IRF8. J Immunol.
32. Habibzay M, Saldana JI, Goulding J, Lloyd CM, Hussell T (2012) Altered regulation of Toll-like receptor responses impairs antibacterial immunity in the allergic lung. Mucosal Immunol 5:524-534.
33. Bosio CM, Dow SW (2005) Francisella tularensis induces aberrant activation of pulmonary dendritic cells. J Immunol 175:6792-6801. (Pubitemid 41598924)
34. Anderson RV, Crane DD, Bosio CM (2010) Long lived protection against pneumonic tularemia is correlated with cellular immunity in peripheral, not pulmonary, organs. Vaccine 28:6562-6572.